Federal Register Notice: FDA is making available a guidance for industry entitled Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. This guidance provides a description and basis for a process by which a maximum recommended starting dose may be selected for a first-in-human clinical trial of a therapeutic in adult healthy volunteers. To download this guidance, click here. To view this notice, click here.